Laboratory tests in primary care · by Dr Solange Déplanque and Dr Michaël Rochoy

Chondrocalcinosis (calcium pyrophosphate crystal disease): look for a metabolic cause

Rheumatology · Known disease · updated 2026-10-31

BioMG follows French guidelines. Adapt it to the guidelines and the tests available where you practise.

Frequency: Radiographic chondrocalcinosis: rare before 60, 10 to 15% between 65 and 75, more than 30% beyond [1]

Chondrocalcinosis found or confirmed CPPD arthritis: look for causes

Fasting sample.

Fasting laboratory tests

Detailed explanation and international comparison (in French): read it in English (machine translation)

Also consider

Sources (5)
  1. Collège français des enseignants en rhumatologie (COFER). Item 198 : Arthropathie microcristalline (section 3, rhumatisme à cristaux de pyrophosphate de calcium). Référentiel en ligne du Collège (lecofer.org), consulté le 11 octobre 2026.
  2. Zhang W, Doherty M, Bardin T, et al. European League Against Rheumatism recommendations for calcium pyrophosphate deposition. Part I: terminology and diagnosis. Ann Rheum Dis. 2011;70(4):563-70.
  3. Abhishek A, Tedeschi SK, Pascart T, et al. The 2023 ACR/EULAR classification criteria for calcium pyrophosphate deposition disease. Ann Rheum Dis. 2023;82(10):1248-57.
  4. Richette P, Bardin T, Doherty M. An update on the epidemiology of calcium pyrophosphate dihydrate crystal deposition disease. Rheumatology (Oxford). 2009;48(7):711-5.
  5. Rosenthal AK, Ryan LM. Calcium Pyrophosphate Deposition Disease. N Engl J Med. 2016;374(26):2575-2584.